Skip to main content Accesibility Help

Cardiovascular medication and falls

  • Adam Darowski (a1) and Robert Whiting (a1)

There are inadequate data to formulate evidence-based guidelines on cardiovascular medication and falls. A critical systematic review of medication as a risk factor for falls concluded that there was a weak association between drugs that reduce blood pressure and falls. The population studies reviewed, looking for an association between cardiovascular drug usage and falls, consisted of subjects who were much younger and who had a much lower drug burden when compared with the older clinic population. The magnitude of the effect of cardiovascular medications on falls may therefore have been underestimated in these studies.

Two observational studies in falls clinics showed significant reductions in falls and syncope following withdrawal of cardiovascular medication, with improvements in symptoms, in tilt-table parameters predictive of syncope, and in measures of gait and balance.

There are no randomized controlled trials of the effect of cardiovascular drug withdrawal on falls. An expert audience of 200 members attending the 2009 British Geriatrics Society Falls Section Conference held the unanimous opinion that cardiovascular medications were a significant cause of falls in older people.

Corresponding author
Address for correspondence: Dr Adam Darowski, Department of Clinical Geratology, Level 4, Academic Block, John Radcliffe Hospital, Oxford OX3 9DU, UK. Email:
Hide All
1Leipzig, RM, Cumming, RG, Tinetti, ME. Drugs and falls in older people: a systemic review and meta-analysis II: cardiac and analgesic drugs. J Am Geriatr Soc 1999; 47: 4050.
2Hartikainen, S, Lonnroos, E, Louhivuori, K. Medication as a risk factor for falls: critical systematic review. J Gerontology 2007; 62A: 1172–81.
3Woolcott, JC, Richardson, KJ, Wiens, MO, Patel, B, Marin, J, Khan, KM, Marra, CA. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 2009; 169: 195260.
4Feder, G, Cryer, C, Donovan, S, Carter, Y. Guidelines for the prevention of falls in people over 65. BMJ 2000; 321: 1007–11.
5Darowski, A, Chambers, SCF, Chambers, DJ. Antidepressants and falls. Drugs Aging 2009; 26: 381–94.
6Campbell, AJ, Robertson, MC, Gardner, MM, Norton, RN, Buchner, DM. Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomized, controlled trial. J Am Geriatr Soc 1999; 47: 850–53.
7Alsop, K, MacMahon, M. Withdrawing cardiovascular medications at a syncope clinic. Postgrad Med J 2001; 77: 403–5.
8Van Der Velde, N, Ziere, B, Van Der Cammen, TJM. Drugs and falls in older persons: potential for reversibility? Eur J Geriatrics 2004; 6: 187–92.
9Van Der Velde, N, Van Den Meiracker, AH, Pols, HA, Stricker, BH, Van Der Cammen, TJ. Withdrawal of fall-risk-increasing drugs in older persons: effect on tilt-table test outcomes. J Am Geriatr Soc 2007; 55: 734–39.
10Darowski, A. Falls: The Facts. Oxford, OUP, 2008.
11Sorond, FA, Galica, A, Serrador, JM, Kiely, DK, Iloputaife, I, Cupples, LA, Lipsitz, LA. Cerebrovascular hemodynamics, gait, and falls in an elderly population. Neurology 2010; 74: 1627–33.
12Turnheim, K. Geriatric pharmacology: Pharmacokinetics and pharmacodynamics in the elderly, geriatric and nootropic drugs. Wien Klin Wochenschr 1995; 107: 349–56.
13Mannesse, CK, Van Der Cammen, TJM. Adverse drug reactions in three older patients, even without changes in medication. Ned Tijdschr Geneesk 2003; 147: 585–87.
14Mannesse, CK, Derkx, FMH, De Ridder, MAJ, Man in't Veld, AJ, Van Der Cammen, TJM. Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing 2000; 29: 203–10.
15Müller, ME, Van Der Velde, N, Krulder, JWM, Van Der Cammen, TJM. Syncope and falls due to timolol eye drops. BMJ 2006; 332: 960–61.
16Van Der Velde, N, Ziere, B, Van Der Cammen, TJM. Falls in three patients due to timolol eye drops, tolterodine, and flecainide. J Gerontol A Biol Sci Med Sci 2004; 12: 1243–44.
17Zeeh, J, Platt, D. The ageing liver. Gerontology 2002; 48: 121–27.
18Jansen, PAF. Pitfalls in drug use of the elderly. Gebu 2000; 34: 5359.
19Gral, T, Young, M. Measured versus estimated creatinine clearance in the elderly as an index of renal function. J Am Geriatr Soc 2002; 50: 1629–37.
20Jansen, PAF. Clinical relevant drug interactions in the elderly. Ned Tijdschr Geneesk 2003; 147: 595–99.
21Centers for Disease Control and Prevention. Leading Causes of Non-fatal Injury Reports. Available at: (accessed 24 May 2010).
22Grimley Evans, J. Evidence-based and evidence-biased medicine. Age Ageing 1995: 24: 461–63.
23Aguado, A, López, F, Miravet, S, Oriol, P, Fuentes, MI, Henares, B, Badia, T, Esteve, L, Peligro, J. Hypertension in the very old; prevalence, awareness, treatment and control: a cross-sectional population-based study in a Spanish municipality. BMC Geriatrics 2009; 9: 16.
24Staessen, JA, Gasowski, J, Wang, JG, Thijs, L, Den Hond, E, Boissel, JP, Coope, J, Ekbom, T, Gueyffier, F, Liu, L, Kerlikowske, K, Pocock, S, Fagard, RH. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000; 355: 865–72.
25Dahlöf, B, Lindholm, LH, Hansson, L, Scherstén, B, Ekbom, T, Wester, PO. Morbidity and mortality in the Swedish Trial in Old Patients with hypertension (STOP-hypertension). Lancet 1991; 338: 1281–85.
26SHEP Co-operative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255–64.
27Cooper, C, Melton, LJ III. Epidemiology of osteoporosis. Trends Endocrinol Metab 1992; 314: 224–29.
28Staessen, JA, Fagard, R, Thijs, L, Celis, H, Arabidze, GG, Birkenhäger, WH, Bulpitt, CJ, de Leeuw, PW, Dollery, CT, Fletcher, AE, Forette, F, Leonetti, G, Nachev, C, O'Brien, ET, Rosenfeld, J, Rodicio, JL, Tuomilehto, J, Zanchetti, A. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350: 757–64.
29Liu, L, Wang, JG, Gong, L, Liu, G, Staessen, JA, for the Systolic Hypertension in China (Syst-China) Collaborative Group. Comparison of active treatment and placebo for older patients with isolated systolic hypertension. J Hypertens 1998; 16: 1823–29.
30Staessen, J, Bulpitt, C, Clement, D et al. Relation between mortality and treated blood pressure in elderly patients with hypertension: Report of the European Working Party on High Blood Pressure in the Elderly. BMJ 1989; 298: 1552–56.
31Coope, J, Warrender, TS. Randomised trial of treatment of hypertension in elderly patients in primary care. BMJ 1986; 293: 1145–51.
32MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992; 304: 405–12.
33Bulpitt, CJ, Peters, R, Staessen, JA, Thijs, L, de Vernejoul, MC, Fletcher, AE, Beckett, NS. Fracture risk and the use of a diuretic (indapamide sr) ± perindopril: a substudy of the Hypertension in the Very Elderly Trial (HYVET). Trials 2006; 7: 33
34Beckett, NS, Peters, R, Fletcher, AE, Staessen, JA, Liu, L, Dumitrascu, D, Stoyanovsky, V, Antikainen, RL, Nikitin, Y, Anderson, C, Belhani, A, Forette, F, Rajkumar, C, Thijs, L, Banya, W, Bulpitt, CJ; HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. NEJM 2008; 358: 1887–98.
35Heiat, A, Gross, CP, Krumholz, HM. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med 2002; 162: 1682–88.
36Komajda, M, Hanon, O, Hochadel, M, Lopez-Sendon, JL, Follath, F, Ponikowski, P, Harjola, VP, Drexler, H, Dickstein, K, Tavazzi, L, Nieminen, M. Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II. Eur Heart J 2009; 30: 478–86.
37Cleland, JG, Tendera, MAdamus, JFreemantle, N, Polonski, L, Taylor, J; PEP-CHF Investigators. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 2006; 27: 2338–45.
38Soteriades, ES, Evans, JC, Larson, MG, Chen, MH, Chen, L, Benjamin, EJ, Levy, D. Incidence and prognosis of syncope. N Engl J Med 2002; 347: 878–85.
39Lipsitz, LA, Pluchino, FC, Wei, JY et al. Syncope in an elderly instituzionalized population: prevalence, incidence and associated risk. Q J Med 1985; 55: 4554.
40Shaw, FE, Kenny, RA. The overlap between syncope and falls in the elderly. Postgrad Med J 1997; 73: 635–39.
41Nevitt, MC, Cummings, SR, Kidd, S. Risk factors for recurrent non-syncopal falls. A prospective study. JAMA 1989; 261: 2663–67.
42McIntosh, SJ, da Costa, D, Kenny, RA. Outcome of an integrated approach to the investigation of dizziness, falls and syncope in elderly patients referred to a syncope clinic. Age Ageing 1993; 22: 5355.
43Davies, AJ, Kenny, RA. Falls presenting to the Accident and Emergency Department: types of presentation and risk factor profile. Age Ageing 1996; 25: 362–66.
44Brignole, M, Alboni, P, Benditt, DG, Bergfeldt, L, Blanc, JJ, Bloch Thomsen, PE, van Dijk, JG, Fitzpatrick, A, Hohnloser, S, Janousek, J, Kapoor, W, Kenny, RA, Kulakowski, P, Masotti, G, Moya, A, Raviele, A, Sutton, R, Theodorakis, G, Ungar, A, Wieling, W; Task Force on Syncope, European Society of Cardiology. Guidelines on management (diagnosis and treatment) of syncope – update 2004. Europace 2004; 6: 467537.
45Carey, BJ, Potter, JF. Cardiovascular causes of falls. Age Ageing 2001; 30: 1924.
46Iyer, S, Naganathan, V, McLachlan, AJ, Le Couteur, DG. Medication withdrawal trials in people aged 65 years and older. Drugs Aging 2008; 25: 1021–31.
47Poon, IO, Braun, U. High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans. J Clin Pharm Ther 2005; 30: 173–78.
48Kenny, RA, Kalaria, R, Ballard, C. Neurocardiovascular instability in cognitive impairment and dementia. Ann NY Acad Sci 2002; 977: 183–95.
49Novak, V, Novak, P, Spies, LM, Low, PA. Autoregulation of cerebral blood flow in orthostatic hypotension. Stroke 1998; 29: 104–11.
50Parry, SW, Tan, MP. An approach to the evaluation and management of syncope in adults. BMJ 2010; 340: 880.
51Graafmans, WC, Ooms, ME, Hofstee, HM, Bezemer, PD, Bouter, LM, Lips, P. Falls in the elderly: a prospective study of risk factors and risk profiles. Am J Epidemiol 1996; 143: 1129–36.
52Seifer, C, Kenny, RA. The prevalence of falls in older persons paced for atrioventricular block and sick sinus syndrome. Am J Geriatric Cardiol 2008; 12: 298307.
53Moya, A, Sutton, R, Ammirati, F et al. Guidelines on diagnosis and management of syncope – version 2009. Eur Heart J 2009; 30: 2631–71.
54Parry, SW, Matthews, I. The implantable loop recorder in older patients with syncope: is sooner better? Age Ageing 2010; 39: 284–85.
55Kenny, RA, Richardson, DA, Steen, N, Bexton, RS, Shaw, FE, Bond, J. Carotid sinus syndrome: modifiable risk factors for non-accidental falls in older adults (Safe Pace). J Am Coll Cardiol 2001; 38: 1491–96.
56Kumar, NP, Thomas, A, Mudd, P, Morris, RO, Masud, T. The usefulness of carotid sinus massage in different patient groups. Age Ageing 2003; 32: 666–69.
57Kenny, RA, McIntosh, S. Carotid sinus syndrome. In Kenny, RA (ed), Syncope in the Older Patient. London: Chapman & Hall, 1996: pp. 107–23.
58Alboni, P, Brignole, M, Menozzi, C, Raviele, A, Del Rosso, A, Dinelli, M, Bettiol, K, Bottoni, N, Solano, A. Clinical spectrum of neurally mediated reflex syncopes. Europace 2004; 6: 5562.
59Bergland, A, Wyller, TB. Risk factors for serious fall related injury in elderly women living in home. Inj Prev 2004; 10: 308–13.
60Rozenfeld, S, Camacho, LA, Veras, P. Medications as a risk factor for falls in older women in Brazil. Rev Panam Salud Publica 2003; 13: 369–75.
61Chu, LW, Chi, I, Chiu, AY. Incidence and predictors of falls in the Chinese elderly. Ann Acad Med Singapore 2005; 3: 6072.
62Lawlor, DA, Patel, R, Ebrahim, S. Association between falls in elderly women and chronic diseases and drug use: cross sectional study. BMJ 2003; 327: 712–17.
63Kelly, KD, Pickett, W, Yiannakoulias, N, Rowe, BH, Schopflocher, DP, Svenson, L, Voaklander, DC. Medication use and falls in community-dwelling older persons. Age Ageing 2003; 32: 503–9.
64Lee, JSW, Kwok, T, Leung, PC, Woo, J. Medical illnesses are more important than medications as risk factors of falls in older community dwellers? A cross-sectional study. Age Ageing 2006; 35: 246–51.
65Mustard, CA, Mayer, T. Case-control study of exposure to medication and the risk of injurious falls requiring hospitalisation among nursing home residents. Am J Epidemiol 1997; 145: 738–45.
66Burr, ML, King, S, Davies, HE, Pathy, MS. The effects of discontinuing long-term diuretic therapy in the elderly. Age Ageing 1977; 6: 3845.
67Myers, MG, Weingert, ME, Fisher, RH, Gryfe, CI, Shulman, HS. Unnecessary diuretic therapy in the elderly. Age Ageing 1982; 11: 213–21.
68de Jonge, JW, Knottnerus, JA, van Zutphen, WM, de Bruijne, GA, Struijker Boudier, HA. Short-term effect of withdrawal of diuretic drugs prescribed for ankle oedema. BMJ 1994; 308: 511–13.
69Walma, EP, Hoes, AW, van Dooren, C, Prins, A, Van Der Does, E. Withdrawal of long-term diuretic medication in elderly patients: a double-blind randomised trial. BMJ 1997; 315: 464–68.
70Kario, K, Tobin, JN, Wolfson, LI, Whipple, R, Derby, CA, Singh, D, Marantz, PR, Wassertheil-Smoller, S. Lower standing systolic blood pressure as a predictor of falls in the elderly: a community-based prospective study. J Am Coll Cardiol 2001; 38: 246–52.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Reviews in Clinical Gerontology
  • ISSN: 0959-2598
  • EISSN: 1469-9036
  • URL: /core/journals/reviews-in-clinical-gerontology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed